W E Berdel|S Okamoto - JoVE Visualize

Showing results (71-80 of 942) with videos related to

Pageof 95

Sort By:

Nihon Sanka Fujinka Gakkai Zasshi|October 1, 1985

[Study on the direct inhibitory action of luteinizing hormone-releasing hormone on the steroidogenesis of cultured human corpus luteum cells]S Okamoto

Nippon Ganka Gakkai Zasshi|June 1, 1991

[The influence of the light stimulus on VIP mRNA in VIP containing neurons of the rat suprachiasmatic nucleus]S Okamoto

Shinrigaku Kenkyu : the Japanese Journal of Psychology|August 1, 1991

[Determinants of requesting expressions: referring to a speaker's state]S Okamoto

Attention, Perception & Psychophysics|January 10, 2014

VR-MDS: multidimensional scaling for classification tasks of virtual and real stimuliS Okamoto

Oncology|June 6, 2000

Sequential trimetrexate, 5-fluorouracil and folinic acid are effective and well tolerated in metastatic colorectal carcinoma. The phase II study group of the AIOH Szelényi, P Hohenberger, H Lochs, et al.

Bone Marrow Transplantation|August 11, 2001

Kinetics of standardized large volume leukapheresis (LVL) in patients do not show a recruitment phenomenon of peripheral blood progenitor cells (PBPC)U Cassens, P H Momkvist, M Zuehlsdorf, et al.

Cancer Research|August 15, 1993

Removal of breast cancer cells from bone marrow by in vitro purging with ether lipids and cryopreservationH F Dietzfelbinger, D Kühn, M Zafferani, et al.

Deutsche Medizinische Wochenschrift (1946)|October 25, 2002

[Mutations of growth factor receptor Flt3 in acute myeloid leukemia: transformation of myeloid cells by Ras-dependent and Ras-independent mechanisms]C Müller-Tidow, C Steur, M Mizuki, et al.

Bone Marrow Transplantation|June 26, 1999

Culturing human umbilical cord blood: a comparison of mononuclear vs CD34+ selected cellsT Fietz, W E Berdel, H Rieder, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 1999

Clinical and pharmacologic phase I study of Cemadotin-HCl (LU103793), a novel antimitotic peptide, given as 24-hour infusion in patients with advanced cancer. A study of the Arbeitsgemeinschaft Internistische Onkologie (AIO) Phase I Group and Arbeitsgruppe Pharmakologie in der Onkologie und Haematologie (APOH) Group of the German Cancer SocietyK Mross, W E Berdel, H H Fiebig, et al.

Pageof 95

Showing results (71-80 of 942) with videos related to

Sort By:

Pageof 95

Nihon Sanka Fujinka Gakkai Zasshi|October 1, 1985

[Study on the direct inhibitory action of luteinizing hormone-releasing hormone on the steroidogenesis of cultured human corpus luteum cells]S Okamoto

Nippon Ganka Gakkai Zasshi|June 1, 1991

[The influence of the light stimulus on VIP mRNA in VIP containing neurons of the rat suprachiasmatic nucleus]S Okamoto

Shinrigaku Kenkyu : the Japanese Journal of Psychology|August 1, 1991

[Determinants of requesting expressions: referring to a speaker's state]S Okamoto

Attention, Perception & Psychophysics|January 10, 2014

VR-MDS: multidimensional scaling for classification tasks of virtual and real stimuliS Okamoto

Oncology|June 6, 2000

Sequential trimetrexate, 5-fluorouracil and folinic acid are effective and well tolerated in metastatic colorectal carcinoma. The phase II study group of the AIOH Szelényi, P Hohenberger, H Lochs, et al.

Bone Marrow Transplantation|August 11, 2001

Kinetics of standardized large volume leukapheresis (LVL) in patients do not show a recruitment phenomenon of peripheral blood progenitor cells (PBPC)U Cassens, P H Momkvist, M Zuehlsdorf, et al.

Cancer Research|August 15, 1993

Removal of breast cancer cells from bone marrow by in vitro purging with ether lipids and cryopreservationH F Dietzfelbinger, D Kühn, M Zafferani, et al.

Deutsche Medizinische Wochenschrift (1946)|October 25, 2002

[Mutations of growth factor receptor Flt3 in acute myeloid leukemia: transformation of myeloid cells by Ras-dependent and Ras-independent mechanisms]C Müller-Tidow, C Steur, M Mizuki, et al.

Bone Marrow Transplantation|June 26, 1999

Culturing human umbilical cord blood: a comparison of mononuclear vs CD34+ selected cellsT Fietz, W E Berdel, H Rieder, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 1999

Clinical and pharmacologic phase I study of Cemadotin-HCl (LU103793), a novel antimitotic peptide, given as 24-hour infusion in patients with advanced cancer. A study of the Arbeitsgemeinschaft Internistische Onkologie (AIO) Phase I Group and Arbeitsgruppe Pharmakologie in der Onkologie und Haematologie (APOH) Group of the German Cancer SocietyK Mross, W E Berdel, H H Fiebig, et al.

Pageof 95